Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Cumulative Incidence of Thromboembolism and Prognostic Impact of Stroke in BRAF V600E-mutant Non-small-cell Lung Cancer.

Anticancer research - 1 Feb 2023

Yamada Sho, Sekine Akimasa, Hagiwara Eri, Onodera Yoko, Tabata Erina, Ikeda Satoshi, Kitamura Hideya, Baba Tomohisa, Komatsu Shigeru, Ogura Takashi

Abstract excerpt

BACKGROUND/AIM: Cancer and ischemic stroke are closely associated. Thromboembolism susceptibility in lung cancer may differ depending on oncogenic alterations. However, the clinical characteristics of thromboembolism in patients with BRAF-mutant non-small-cell lung cancer remain unknown. Thus, this study aimed to evaluate the cumulative incidence of thromboembolism in this population and describe such cases in...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Carcinoma, Non-Small-Cell Lung
Share to Incidence

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Lung Neoplasms

Share to Prognosis

Share to Proto-Oncogene Proteins B-raf

Share to Stroke

Share to Thromboembolism

Share to Venous Thromboembolism

Source

Identifiers

PMID: 36697098
DOI: 10.21873/anticanres.16237

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Cumulative Incidence of Thromboembolism and Prognostic Impact of Stroke in BRAF V600E-mutant Non-small-cell Lung Cancer.PMID 36697098Read ↗

Brief report: High incidence of peridiagnosis thromboembolic events in patients with BRAF-mutant lung cancer.Semantic proximity Read ↗

Risk of thromboembolism in patients with ALK- and EGFR-mutant lung cancer: A cohort study.Semantic proximity Read ↗

Risk factors and prognostic impact of venous thromboembolism in Asian patients with non-small cell lung cancer.Semantic proximity Read ↗

Association between oncogenic status and risk of venous thromboembolism in patients with non-small cell lung cancer.Semantic proximity Read ↗

Risk of thromboembolism in non-small-cell lung cancers patients with different oncogenic drivers, including ROS1, ALK, and EGFR mutations.Semantic proximity Read ↗

Common genetic driver mutation in NSCLC and their association with thromboembolic events: A retrospective study.Semantic proximity Read ↗

Mutations in NSCLC and their link with lung cancer-associated thrombosis: a case-control study.Semantic proximity Read ↗

Management of nonbacterial thrombotic endocarditis (NBTE) in advanced non-small cell lung cancer (NSCLC) patients with driver mutation: two case reports.Semantic proximity Read ↗

DWI Lesion Patterns in Cancer-Related Stroke--Specifying the Phenotype.Semantic proximity Read ↗

Cardiovascular events and venous thromboembolism after primary malignant and non-malignant brain tumour diagnosis: a population matched cohort study in Wales (United Kingdom)Semantic proximity Read ↗

Cerebral infarction after treatment with dabrafenib plus trametinib for BRAF-V600E-positive non-small cell lung cancer: A case report.Semantic proximity Read ↗

Association between genetic mutations and risk of venous thromboembolism in patients with solid tumor malignancies: A systematic review and meta-analysis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.